Clinical Trial Update: S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin

View source ↗

Summary

A completed study evaluating biomarkers in samples from acute myeloid leukemia patients treated with standard chemotherapy with or without gemtuzumab ozogamicin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia | Status: COMPLETED